Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023
Upgrades
For Airbnb Inc (NASDAQ:ABNB), Argus Research upgraded the previous rating of Hold to Buy. Airbnb earned $0.48 in the fourth quarter, compared to $0.08 in the year-ago quarter. The stock has a 52-week-high of $179.09 and a 52-week-low of $81.91. At the end of the last trading period, Airbnb closed at $123.53.
For Celsius Holdings Inc (NASDAQ:CELH), Credit Suisse upgraded the previous rating of Neutral to Outperform. For the third quarter, Celsius Holdings had an EPS of $0.67, compared to year-ago quarter EPS of $0.03. The current stock performance of Celsius Holdings shows a 52-week-high of $122.24 and a 52-week-low of $38.31. Moreover, at the end of the last trading period, the closing price was at $90.02.
JP Morgan upgraded the previous rating for Revolution Medicines Inc (NASDAQ:RVMD) from Neutral to Overweight. In the fourth quarter, Revolution Medicines showed an EPS of $0.63, compared to $0.71 from the year-ago quarter. At the moment, the stock has a 52-week-high of $31.37 and a 52-week-low of $14.08. Revolution Medicines closed at $24.37 at the end of the last trading period.
According to Piper Sandler, the prior rating for Broadmark Realty Capital Inc (NYSE:BRMK) was changed from Underweight to Neutral. For the fourth quarter, Broadmark Realty Capital had an EPS of $0.09, compared to year-ago quarter EPS of $0.18. The stock has a 52-week-high of $8.91 and a 52-week-low of $3.52. At the end of the last trading period, Broadmark Realty Capital closed at $4.92.
Piper Sandler upgraded the previous rating for HomeTrust Bancshares Inc (NASDAQ:HTBI) from Neutral to Overweight. For the second quarter, HomeTrust Bancshares had an EPS of $0.90, compared to year-ago quarter EPS of $0.68. The stock has a 52-week-high of $31.11 and a 52-week-low of $21.55. At the end of the last trading period, HomeTrust Bancshares closed at $28.52.
Goldman Sachs upgraded the previous rating for Krystal Biotech Inc (NASDAQ:KRYS) from Neutral to Buy. In the fourth quarter, Krystal Biotech showed an EPS of $1.25, compared to $0.94 from the year-ago quarter. The stock has a 52-week-high of $85.65 and a 52-week-low of $47.67. At the end of the last trading period, Krystal Biotech closed at $78.14.
See all analyst ratings upgrades.
Downgrades
For Anywhere Real Estate Inc (NYSE:HOUS), Keefe, Bruyette & Woods downgraded the previous rating of Outperform to Market Perform. In the fourth quarter, Anywhere Real Estate showed an EPS of $0.85, compared to $0.38 from the year-ago quarter. The stock has a 52-week-high of $12.96 and a 52-week-low of $5.82. At the end of the last trading period, Anywhere Real Estate closed at $5.95.
Goldman Sachs downgraded the previous rating for Arconic Corp (NYSE:ARNC) from Neutral to Sell. For the fourth quarter, Arconic had an EPS of $0.31, compared to year-ago quarter EPS of $0.25. The stock has a 52-week-high of $31.91 and a 52-week-low of $16.33. At the end of the last trading period, Arconic closed at $22.13.
B of A Securities downgraded the previous rating for Kosmos Energy Ltd (NYSE:KOS) from Buy to Neutral. For the fourth quarter, Kosmos Energy had an EPS of $0.23, compared to year-ago quarter EPS of $0.13. The current stock performance of Kosmos Energy shows a 52-week-high of $8.55 and a 52-week-low of $4.42. Moreover, at the end of the last trading period, the closing price was at $8.55.
Argus Research downgraded the previous rating for Williams Companies Inc (NYSE:WMB) from Buy to Hold. In the fourth quarter, Williams Companies showed an EPS of $0.53, compared to $0.39 from the year-ago quarter. At the moment, the stock has a 52-week-high of $37.97 and a 52-week-low of $28.30. Williams Companies closed at $30.70 at the end of the last trading period.
For Domino's Pizza Inc (NYSE:DPZ), Northcoast Research downgraded the previous rating of Buy to Neutral. For the fourth quarter, Domino's Pizza had an EPS of $4.43, compared to year-ago quarter EPS of $4.25. The current stock performance of Domino's Pizza shows a 52-week-high of $448.99 and a 52-week-low of $291.00. Moreover, at the end of the last trading period, the closing price was at $295.63.
For Dick's Sporting Goods Inc (NYSE:DKS), Citigroup downgraded the previous rating of Buy to Neutral. For the third quarter, Dick's Sporting Goods had an EPS of $2.60, compared to year-ago quarter EPS of $3.19. The current stock performance of Dick's Sporting Goods shows a 52-week-high of $138.43 and a 52-week-low of $63.45. Moreover, at the end of the last trading period, the closing price was at $129.76.
According to UBS, the prior rating for OGE Energy Corp (NYSE:OGE) was changed from Buy to Neutral. For the fourth quarter, OGE Energy had an EPS of $0.25, compared to year-ago quarter EPS of $0.27. At the moment, the stock has a 52-week-high of $42.91 and a 52-week-low of $33.28. OGE Energy closed at $36.57 at the end of the last trading period.
According to Raymond James, the prior rating for Argo Group International Holdings Ltd (NYSE:ARGO) was changed from Market Perform to Underperform. Argo Gr Intl Hldgs earned $2.69 in the fourth quarter, compared to $1.77 in the year-ago quarter. At the moment, the stock has a 52-week-high of $45.26 and a 52-week-low of $19.00. Argo Gr Intl Hldgs closed at $29.18 at the end of the last trading period.
B of A Securities downgraded the previous rating for DISH Network Corp (NASDAQ:DISH) from Buy to Underperform. DISH Network earned $1.47 in the fourth quarter, compared to $0.87 in the year-ago quarter. The stock has a 52-week-high of $33.74 and a 52-week-low of $12.17. At the end of the last trading period, DISH Network closed at $12.20.
For LendingTree Inc (NASDAQ:TREE), Susquehanna downgraded the previous rating of Positive to Neutral. LendingTree earned $0.38 in the fourth quarter, compared to $0.14 in the year-ago quarter. The current stock performance of LendingTree shows a 52-week-high of $129.30 and a 52-week-low of $17.59. Moreover, at the end of the last trading period, the closing price was at $32.20.
DA Davidson downgraded the previous rating for Holley Inc (NYSE:HLLY) from Buy to Neutral. In the third quarter, Holley showed an EPS of $0.04, compared to $0.12 from the year-ago quarter. At the moment, the stock has a 52-week-high of $14.68 and a 52-week-low of $1.88. Holley closed at $2.25 at the end of the last trading period.
For FuboTV Inc (NYSE:FUBO), Evercore ISI Group downgraded the previous rating of Outperform to In-Line. In the fourth quarter, FuboTV showed an EPS of $0.39, compared to $0.57 from the year-ago quarter. The current stock performance of FuboTV shows a 52-week-high of $8.86 and a 52-week-low of $1.61. Moreover, at the end of the last trading period, the closing price was at $2.00.
For Thomson Reuters Corp (NYSE:TRI), National Bank Financial Inc downgraded the previous rating of Outperform to Sector Perform. Thomson Reuters earned $0.73 in the fourth quarter, compared to $0.43 in the year-ago quarter. At the moment, the stock has a 52-week-high of $125.32 and a 52-week-low of $91.55. Thomson Reuters closed at $121.67 at the end of the last trading period.
William Blair downgraded the previous rating for Focus Financial Partners Inc (NASDAQ:FOCS) from Outperform to Market Perform. For the fourth quarter, Focus Finl Partners had an EPS of $0.99, compared to year-ago quarter EPS of $0.94. The current stock performance of Focus Finl Partners shows a 52-week-high of $52.62 and a 52-week-low of $30.27. Moreover, at the end of the last trading period, the closing price was at $51.75.
Morgan Stanley downgraded the previous rating for Fulcrum Therapeutics Inc (NASDAQ:FULC) from Overweight to Equal-Weight. Fulcrum Therapeutics earned $0.51 in the third quarter, compared to $0.57 in the year-ago quarter. The current stock performance of Fulcrum Therapeutics shows a 52-week-high of $24.79 and a 52-week-low of $3.21. Moreover, at the end of the last trading period, the closing price was at $5.80.
See all analyst ratings downgrades.
Initiations
With an Outperform rating, SVB Leerink initiated coverage on Disc Medicine Inc (NASDAQ:IRON). The price target seems to have been set at $36.00 for Disc Medicine. The stock has a 52-week-high of $25.59 and a 52-week-low of $15.00. At the end of the last trading period, Disc Medicine closed at $24.39.
With a Buy rating, Guggenheim initiated coverage on Structure Therapeutics Inc (NASDAQ:GPCR). The price target seems to have been set at $50.00 for Structure Therapeutics. The stock has a 52-week-high of $27.46 and a 52-week-low of $20.80. At the end of the last trading period, Structure Therapeutics closed at $24.00.
Cowen & Co. initiated coverage on AbCellera Biologics Inc (NASDAQ:ABCL) with an Outperform rating. For the fourth quarter, AbCellera Biologics had an EPS of $0.10, compared to year-ago quarter EPS of $0.19. The current stock performance of AbCellera Biologics shows a 52-week-high of $14.97 and a 52-week-low of $5.42. Moreover, at the end of the last trading period, the closing price was at $8.43.
RBC Capital initiated coverage on IDEAYA Biosciences Inc (NASDAQ:IDYA) with an Outperform rating. The price target for IDEAYA Biosciences is set to $25.00. In the third quarter, IDEAYA Biosciences showed an EPS of $0.04, compared to $0.31 from the year-ago quarter. The current stock performance of IDEAYA Biosciences shows a 52-week-high of $19.14 and a 52-week-low of $8.14. Moreover, at the end of the last trading period, the closing price was at $17.35.
For Magenta Therapeutics Inc (NASDAQ:MGTA), HC Wainwright & Co. initiated coverage, by setting the current rating at Neutral. Magenta Therapeutics earned $0.27 in the third quarter, compared to $0.30 in the year-ago quarter. The stock has a 52-week-high of $3.62 and a 52-week-low of $0.32. At the end of the last trading period, Magenta Therapeutics closed at $0.81.
With an Outperform rating, BMO Capital initiated coverage on Structure Therapeutics Inc (NASDAQ:GPCR). The price target seems to have been set at $40.00 for Structure Therapeutics. At the moment, the stock has a 52-week-high of $27.46 and a 52-week-low of $20.80. Structure Therapeutics closed at $24.00 at the end of the last trading period.
With a Buy rating, Jefferies initiated coverage on Structure Therapeutics Inc (NASDAQ:GPCR). The price target seems to have been set at $34.00 for Structure Therapeutics. The current stock performance of Structure Therapeutics shows a 52-week-high of $27.46 and a 52-week-low of $20.80. Moreover, at the end of the last trading period, the closing price was at $24.00.
Piper Sandler initiated coverage on OPAL Fuels Inc (NASDAQ:OPAL) with an Overweight rating. The price target for OPAL Fuels is set to $12.00. The current stock performance of OPAL Fuels shows a 52-week-high of $12.35 and a 52-week-low of $5.82. Moreover, at the end of the last trading period, the closing price was at $7.94.
With an Overweight rating, Piper Sandler initiated coverage on Clean Energy Fuels Corp (NASDAQ:CLNE). The price target seems to have been set at $8.00 for Clean Energy Fuels. At the moment, the stock has a 52-week-high of $8.65 and a 52-week-low of $4.02. Clean Energy Fuels closed at $5.73 at the end of the last trading period.
Piper Sandler initiated coverage on Aemetis Inc (NASDAQ:AMTX) with an Underweight rating. The price target for Aemetis is set to $3.00. For the third quarter, Aemetis had an EPS of $0.46, compared to year-ago quarter EPS of $0.55. At the moment, the stock has a 52-week-high of $16.06 and a 52-week-low of $3.62. Aemetis closed at $3.85 at the end of the last trading period.
With a Buy rating, Loop Capital initiated coverage on Axcelis Technologies Inc (NASDAQ:ACLS). The price target seems to have been set at $150.00 for Axcelis Technologies. In the fourth quarter, Axcelis Technologies showed an EPS of $1.71, compared to $1.05 from the year-ago quarter. At the moment, the stock has a 52-week-high of $129.71 and a 52-week-low of $46.41. Axcelis Technologies closed at $125.29 at the end of the last trading period.
With an Outperform rating, Oppenheimer initiated coverage on Nurix Therapeutics Inc (NASDAQ:NRIX). The price target seems to have been set at $25.00 for Nurix Therapeutics. For the fourth quarter, Nurix Therapeutics had an EPS of $0.87, compared to year-ago quarter EPS of $0.85. The stock has a 52-week-high of $19.91 and a 52-week-low of $7.52. At the end of the last trading period, Nurix Therapeutics closed at $8.98.